ARTICLE | Company News
Agouron other research news
October 25, 1993 7:00 AM UTC
AGPH described the de novo design of a previously unknown class of orally active, non-peptide inhibitors of HIV protease at the Interscience Conference on Antimicrobial Agents and Chemotherapy in New Orleans. The company used computer-aided design of inhibitors based on the protein structure of the enzyme. ...